Raymond James Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$88.2M Buy
270,450
+1,480
+0.6% +$483K 0.03% 519
2025
Q1
$72.6M Sell
268,970
-8,516
-3% -$2.3M 0.03% 544
2024
Q4
$65.3M Buy
+277,486
New +$65.3M 0.02% 590